<DOC>
	<DOC>NCT00141661</DOC>
	<brief_summary>A 10-week safety and tolerability study of a potential treatment for mild to moderate Alzheimer's disease.</brief_summary>
	<brief_title>A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis of probably Alzheimer's disease for at least 1 year. Mini Mental State Exam (MMSE) score between 1226 at screening. Participants must be receiving a cholinesterase inhibitor and/or memantine for at least 4 months, and on a stable dose for at least 2 months. Current evidence of a neurological or psychiatric illness that could contribute to dementia. Living alone. Poorly controlled high blood pressure.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Interventional, Alzheimer, Safety and Tolerability</keyword>
</DOC>